{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-09-09", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "3d2be2bb-a0ea-4fb6-85de-bca41fbb9809", "code": "P21452", "type": "PRIMARY", "url": "http://www.uniprot.org/uniprot/P21452?sort=score", "code_system": "UNIPROT", "references": [ "3828a254-9334-47fa-aad9-ee9640ac4027" ] }, { "uuid": "60326f5a-1238-4e5c-ad09-ff06f3fc2a9f", "code": "P21452", "type": "PRIMARY", "url": "https://pharos.nih.gov/idg/search?q=P21452", "code_system": "PHAROS", "references": [ "3828a254-9334-47fa-aad9-ee9640ac4027" ] }, { "uuid": "22a60ee0-e27b-497f-862a-d680072e2e31", "code": "79AAW649HW", "type": "PRIMARY", "code_system": "FDA UNII" } ], "substance_class": "protein", "references": [ { "uuid": "5b1be9bd-275f-43a8-891f-2b9ec5aa263b", "citation": "http://www.uniprot.org/uniprot/P21452", "url": "http://www.uniprot.org/uniprot/P21452", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "59400c1a-d197-4adf-ad26-9c15f3851f86", "citation": "UNIPROT", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "249abc9c-cfee-401c-8b8d-0602ae479471", "citation": "http://www.uniprot.org/uniprot/P21452?sort=score", "url": "http://www.uniprot.org/uniprot/P21452?sort=score", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3828a254-9334-47fa-aad9-ee9640ac4027", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493393386000, "tags": [ "NOMEN" ] }, { "uuid": "2d36a400-5028-4f14-a24b-bc11429c4ba5", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a2432284-9fae-4996-b729-7f7aa5a5cc81", "citation": "Boot, Johan D., et al. \"Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.\" American journal of respiratory and critical care medicine 175.5 (2007): 450-457.", "url": "Boot, Johan D., et al. \"Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.\" American journal of respiratory and critical care medicine 175.5 (2007): 450-457.", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "106902e3-5b4b-4a0b-8841-28bba1988b83", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208051Orig1s000MultidisciplineR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true }, { "uuid": "ef3ace07-18f7-4e92-a102-5922f560815d", "citation": "Tack J, Schumacher K, Tonini G, Scartoni S, Capriati A, Maggi CA; Iris-2 investigators. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS. Gut. 2017 Aug;66(8):1403-1413. doi: 10.1136/gutjnl-2015-310683. Epub 2016 Apr 15. PMID: 27196574.", "url": "https://pubmed.ncbi.nlm.nih.gov/27196574/", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b129fbad-2e4c-4400-a2c7-fa4c2e6dc16b", "citation": "Emonds-Alt, Xavier, et al. \"SSR240600 [(R)-2-(1-{2-[4-{2-[3, 5-Bis (trifluoromethyl) phenyl] acetyl}-2-(3, 4-dichlorophenyl)-2-morpholinyl] ethyl}-4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor: I. Biochemical and Pharmacological Characterization.\" Journal of Pharmacology and Experimental Therapeutics 303.3 (2002): 1171-1179.", "url": "https://jpet.aspetjournals.org/content/jpet/303/3/1171.full.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "f2908e70-58b6-43d2-a325-ad5cdc78d077", "citation": "Tanaka, Takahiro, et al. \"Effects of TAK-480, a Novel Tachykinin NK2–Receptor Antagonist, on Visceral Hypersensitivity in Rabbits and Ricinoleic Acid–Induced Defecation in Guinea Pigs.\" Journal of pharmacological sciences 120.1 (2012): 15-25.", "url": "https://www.jstage.jst.go.jp/article/jphs/120/1/120_12085FP/_pdf/-char/ja", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d0b76652-5bb6-4953-bd95-83593dbe51a4", "citation": "Beaumont, K., et al. \"Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human.\" Xenobiotica 30.6 (2000): 627-642.", "url": "https://www.tandfonline.com/doi/pdf/10.1080/004982500406453", "doc_type": "JA", "public_domain": true }, { "uuid": "e2ba7394-ae5d-41d6-938c-cdd1cf6c2dad", "citation": "Tanaka, Takahiro, et al. \"Effects of TAK-480, a Novel Tachykinin NK2–Receptor Antagonist, on Visceral Hypersensitivity in Rabbits and Ricinoleic Acid–Induced Defecation in Guinea Pigs.\" Journal of pharmacological sciences 120.1 (2012): 15-25.", "url": "https://www.jstage.jst.go.jp/article/jphs/120/1/120_12085FP/_pdf/-char/ja", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "definition_level": "COMPLETE", "uuid": "bc52106c-693a-45d8-ae09-09590b53c628", "version": "18", "unii": "79AAW649HW", "relationships": [ { "uuid": "0acfb364-584e-4250-a434-59e3d11531cc", "amount": { "uuid": "82f85313-a78b-4232-9c02-c1bb96f3b363", "average": 91, "units": "%" }, "comments": "Neratinib concentration at 10 microM", "qualification": "Percent inhibition of specific binding", "type": "INHIBITOR->OFF-TARGET", "interaction_type": "INHIBITOR", "references": [ "106902e3-5b4b-4a0b-8841-28bba1988b83" ], "related_substance": { "uuid": "ee65d987-b698-4f0e-b39d-a5c7f40c01bf", "refuuid": "9fc83886-7ba4-424d-9b87-debc23fa9ad6", "name": "NERATINIB", "unii": "JJH94R3PWB", "linking_id": "JJH94R3PWB", "ref_pname": "NERATINIB" } }, { "uuid": "4ad31f41-03c4-48be-96d5-28a0278f6f16", "amount": { "uuid": "985be07c-bbb4-49e4-ae02-203dd7549221", "average": 0.3, "high": 0.4, "low": 0.2, "units": "NANOMOLAR" }, "comments": "Tachykinin NK2 receptor antagonist that was developed by Sanofi-Aventis for anti-depressant potential", "qualification": "IC50", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "52b6e2f6-6324-4cda-b216-dbdf3e315d2d", "refuuid": "0cd30d10-4f47-4377-98ee-51ad059e37a0", "name": "SAREDUTANT", "unii": "720U2QK8I5", "linking_id": "720U2QK8I5", "ref_pname": "SAREDUTANT" } }, { "uuid": "d22527d6-379a-4b8c-b63b-ac14ea9452b5", "amount": { "uuid": "15f97408-49d9-49ae-a357-e61344248757" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "02c3678d-e010-41b9-81b7-846e4b643ba0", "refuuid": "9b64f0c3-0eea-4e13-a039-45a9da0fffff", "name": "CS-003 FREE BASE", "unii": "VGDEDKUKP2", "linking_id": "VGDEDKUKP2", "ref_pname": "CS-003 FREE BASE" } }, { "uuid": "dbe1b7b6-8e6c-4112-9fc7-7e04fdc6a3c0", "amount": { "uuid": "a6e16cf7-eb58-41be-bb6e-4eff27729605", "average": 3.1, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "a2432284-9fae-4996-b729-7f7aa5a5cc81" ], "related_substance": { "uuid": "5e54435d-2339-401a-a784-eea92e8095e3", "refuuid": "f648f9df-6d7a-4f1e-a587-3fd3c70bd71a", "name": "AVE-5883", "unii": "YA427LW2Y2", "linking_id": "YA427LW2Y2", "ref_pname": "AVE-5883" } }, { "uuid": "38148eb2-fda4-4519-a669-c52720f4c6b8", "amount": { "uuid": "1096b2a0-eb04-43c3-83c1-8aa5ec3728c7" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "3d127106-4cc5-4291-8dcd-fb02c6d67f84", "refuuid": "147761db-8306-43fa-aceb-0221d473982c", "name": "DNK-333", "unii": "G9BL4978MZ", "linking_id": "G9BL4978MZ", "ref_pname": "DNK-333" } }, { "uuid": "4230499b-c7e5-4df2-936c-5ef368b9010c", "amount": { "uuid": "1c3b9631-db86-4ebb-bb1a-8ba2629b041c" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "5a666049-d7ef-4114-9674-d878d7e9b2e0", "refuuid": "7c33e01c-cd9d-4adc-a268-e3c3abd78f8e", "name": "NEPADUTANT", "unii": "XW59TYL1XH", "linking_id": "XW59TYL1XH", "ref_pname": "NEPADUTANT", "substance_class": "reference" } }, { "uuid": "47d9c254-54e6-4e4c-be2b-2faa02c93023", "amount": { "uuid": "eee24394-6dc8-442e-8c15-52e5c863e4b4" }, "type": "INHIBITOR->TARGET", "references": [ "ef3ace07-18f7-4e92-a102-5922f560815d" ], "related_substance": { "uuid": "422d2102-6f3a-4037-8390-03b1e25bd571", "refuuid": "cf1311b0-7e3b-4cee-a03b-d9b77ae0b02d", "name": "IBODUTANT", "unii": "1H7RSQ28BJ", "linking_id": "1H7RSQ28BJ", "ref_pname": "IBODUTANT", "substance_class": "reference" } }, { "uuid": "8701459f-3a4b-4e12-86c8-6ef11e359eff", "amount": { "uuid": "ad42e1e7-f604-4d54-8d27-93bee21ca5e6" }, "type": "INHIBITOR->TARGET", "references": [ "d0b76652-5bb6-4953-bd95-83593dbe51a4" ], "related_substance": { "uuid": "1c655880-b852-4a36-b632-8d6ca696afc2", "refuuid": "272b4724-6f71-4a85-ba64-ba114dec1658", "name": "UK-224671", "unii": "V7M68E8XRC", "linking_id": "V7M68E8XRC", "ref_pname": "UK-224671", "substance_class": "reference" } }, { "uuid": "23a0c7aa-1e3b-4e2e-88f1-b77cb492b2ec", "amount": { "uuid": "0f9137f4-0ce5-4cab-9aef-ca2997a21673", "average": 0.144, "units": "MICROMOLAR" }, "qualification": "Ki", "type": "WEAK INHIBITOR->OFF TARGET", "related_substance": { "uuid": "adc0ddae-d692-47e6-9afd-462497df7bc4", "refuuid": "83c7cbe5-cdf0-4b8c-bb22-0720b7a221bc", "name": "TALNETANT", "unii": "CZ3T9T146K", "linking_id": "CZ3T9T146K", "ref_pname": "TALNETANT", "substance_class": "reference" } }, { "uuid": "1326dd25-073d-4a7b-8437-f602c4cd7790", "amount": { "uuid": "0864e852-17a9-41dd-b92f-87ca285e877a", "average": 0.14, "units": "MICROMOLAR" }, "comments": "inositol phosphate-1 formation in CHO cells expressing human NK2", "qualification": "IC50", "type": "INHIBITOR->OFF-TARGET", "interaction_type": "BIOASSAY (CELLULAR)", "references": [ "b129fbad-2e4c-4400-a2c7-fa4c2e6dc16b" ], "related_substance": { "uuid": "e0e3348e-4850-4b99-9558-c819f0addf74", "refuuid": "a893043e-834b-46bd-a091-abe8894126ac", "name": "Burapitant", "unii": "E35SK332MS", "linking_id": "E35SK332MS", "ref_pname": "Burapitant", "substance_class": "reference" } }, { "uuid": "3026ec29-3416-4cf4-8d2f-9e66ee904a5b", "amount": { "uuid": "4aff9fa2-b2ea-4f83-9561-7d52aa782482", "average": 0.95, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "f2908e70-58b6-43d2-a325-ad5cdc78d077" ], "related_substance": { "uuid": "d71f93ff-2e5d-4a4d-8057-2e652b0b02cd", "refuuid": "1c5d9953-0f80-49fa-a915-58b9210bbe28", "name": "TAK-480", "unii": "W8A6GX6UTQ", "linking_id": "W8A6GX6UTQ", "ref_pname": "TAK-480", "substance_class": "reference" } }, { "uuid": "f2562f12-99b4-46ad-b806-3002078926ff", "amount": { "uuid": "41568497-7032-4ba6-94c7-e6ff2b61133b", "average": 0.81, "units": "MICROMOLAR" }, "qualification": "IC50", "type": "WEAK INHIBITOR->OFF TARGET", "related_substance": { "uuid": "b8e176e9-b579-4c41-832c-29cf6b6111ce", "refuuid": "449e4860-8ef3-42ea-b2d1-77438902cb9a", "name": "FK-888", "unii": "DZQ7B7BPD4", "linking_id": "DZQ7B7BPD4", "ref_pname": "FK-888", "substance_class": "reference" } } ], "names": [ { "uuid": "6dee2fe1-c08c-41ec-8739-8957529e53b0", "name": "NEUROKININ A RECEPTOR", "stdName": "NEUROKININ A RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "45944e41-60d6-425a-92d5-7bda3ba2fe8d", "name": "NK-2 RECEPTOR", "stdName": "NK-2 RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "fdfb444c-d3d4-48fd-857d-472ae4d16f3e", "name": "NK-2R", "stdName": "NK-2R", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "9fc94ae2-c669-4336-87d6-33a158e5b937", "name": "NK2 receptor", "stdName": "NK2 RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e2ba7394-ae5d-41d6-938c-cdd1cf6c2dad" ], "display_name": false }, { "uuid": "6b3d796f-8ce0-4548-99d5-1a866040ca3c", "name": "NK2R", "stdName": "NK2R", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "1c55c135-bfd9-4eaf-a148-a2896981ee5f", "name": "NKNAR", "stdName": "NKNAR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "69f1b2fa-2b80-4c85-8699-d638f49add63", "name": "SKR", "stdName": "SKR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "16ec3f33-9271-4ce4-a265-75fa0f5cb728", "name": "SUBSTANCE-K RECEPTOR", "stdName": "SUBSTANCE-K RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5b1be9bd-275f-43a8-891f-2b9ec5aa263b", "59400c1a-d197-4adf-ad26-9c15f3851f86" ], "display_name": true }, { "uuid": "38e2d1bd-a481-4c26-a446-654ec708c152", "name": "TAC2R", "stdName": "TAC2R", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false }, { "uuid": "47b24279-36a1-4a96-b216-40187bd588d2", "name": "TACHYKININ RECEPTOR 2", "stdName": "TACHYKININ RECEPTOR 2", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59400c1a-d197-4adf-ad26-9c15f3851f86", "249abc9c-cfee-401c-8b8d-0602ae479471" ], "display_name": false } ], "protein": { "uuid": "41f4c13e-a104-412e-9205-974439a9557a", "glycosylation": { "uuid": "ae14bc55-c9e5-4845-b80d-19b83a1a4266", "glycosylation_type": "HUMAN", "n_glycosylation_sites": [ { "residue_index": 11, "subunit_index": 1 }, { "residue_index": 19, "subunit_index": 1 } ] }, "subunits": [ { "uuid": "d0decc86-1426-41f4-995e-66b50bacf092", "sequence": "MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRRAVPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKLELTPTTSLSTRVNRCHTKETLFMAGDTAPSEATSGEAGRPQDGSGLWFGYGLLAPTKTHVEI", "subunit_index": 1 } ], "references": [ "5b1be9bd-275f-43a8-891f-2b9ec5aa263b" ], "disulfide_links": [ { "sites": [ { "residue_index": 106, "subunit_index": 1 }, { "residue_index": 181, "subunit_index": 1 } ] } ], "protein_sub_type": "", "protein_type": "RECEPTOR", "sequence_origin": "HUMAN", "sequence_type": "COMPLETE" }, "properties": [ { "uuid": "656797f2-0307-4118-ac66-328c9f56cc0c", "name": "MOL_WEIGHT", "type": "amount", "value": { "uuid": "11586eb9-a8ee-4609-ac62-9717f937f438", "units": "DA" }, "defining": false, "property_type": "CHEMICAL" }, { "uuid": "165a2d7e-2a43-4a61-89b9-ab3bc1142153", "name": "Molecular Formula", "value": { "uuid": "1473a991-a15c-47cd-8a4c-5af64e3a6859", "type": "ESTIMATED", "non_numeric_value": "C2055H3128N516O534S26" }, "defining": false, "property_type": "CHEMICAL" } ], "modifications": { "uuid": "dab9d498-4016-4d38-b9c8-414d71abefd4" } } ] }